A Study of Dose Titration of LY2189265 in Overweight Participants With Type 2 Diabetes Mellitus
Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
To study once weekly injections of LY2189265 compared to placebo on blood glucose by
measuring glycosylated hemoglobin (HbA1c) change from baseline after 16 weeks in overweight
Type 2 Diabetes Mellitus participants.